Proton pump inhibitors and risk for Clostridium difficile associated diarrhea
Increased incidence of Clostridium difficile infection (CDI) among in-patients is associated with significant increased mortality, morbidity, and stay in the hospitals. This has occurred despite heightened awareness of the risks of broad-spectrum antibiotics, overall reduction in antibiotic use and...
Main Author: | Sasmita Biswal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-08-01
|
Series: | Biomedical Journal |
Subjects: | |
Online Access: | http://www.biomedj.org/article.asp?issn=2319-4170;year=2014;volume=37;issue=4;spage=178;epage=183;aulast=Biswal |
Similar Items
-
The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
by: Dania Tawam, et al.
Published: (2021-03-01) -
The Analysis of Risk Factors and Clinical-Demographic Characteristics of Patients with Clostridium Dificille Infection as Well as The Outcome of Their Treatment
by: Raković Ivana, et al.
Published: (2016-06-01) -
Long-term effects of proton pump inhibitors
by: Sethu
Published: (2015-04-01) -
Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment
by: Evan Stuart Bradley, et al.
Published: (2019-06-01) -
Is the Incidence of Clostridium difficile in Nosocomial Diarrhoea Underestimated?
by: Özer AKGÜL, et al.
Published: (2018-06-01)